Correction: A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants

Samankaltaisia teoksia

• Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
  Tekijä: Dandan Peng, et al.
  Julkaistu: (2023-04-01)
• The rising SARS‐CoV‐2 JN.1 variant: evolution, infectivity, immune escape, and response strategies
  Tekijä: Yishan Lu, et al.
  Julkaistu: (2024-08-01)
• Correction: A promising mRNA vaccine derived from the JN.1 spike protein confers protective immunity against multiple emerged Omicron variants
  Tekijä: Danyi Ao, et al.
  Julkaistu: (2025-03-01)
• Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial
  Tekijä: Huan Zhou, et al.
  Julkaistu: (2024-06-01)
• Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao
  Tekijä: Hoi Man Ng, et al.
  Julkaistu: (2023-05-01)